Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabay

Showing results (11-20 of 1,119) with videos related to

Pageof 112
Sort By:
Hospital Pharmacy|December 19, 2018
RxLegal: Pharmacist Gag ClausesMichael Gabay
Hospital Pharmacy|December 26, 2017
Biosimilar Substitution LawsMichael Gabay
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2003
IL-1 trap. Regeneron/NovartisCem Gabay
Advances in Experimental Medicine and Biology|January 1, 1981
Serotonergic-dopaminergic interactions: implications for hyperkinetic disordersS Gabay
Hospital Pharmacy|October 9, 2015
Providing Feedback to Colleagues: A Continual ChallengeMichael Gabay
Hospital Pharmacy|January 30, 2016
Regulation of Internet Pharmacies: A Continuing ChallengeMichael Gabay
Hospital Pharmacy|March 28, 2018
The Prescription Drug User Fee Act: Cause for Concern?Michael Gabay
Omega|May 30, 2019
A Nonheroic Cancer Narrative: Body Deterioration, Grief, Disenfranchised Grief, and GrowthGillie Gabay
Qualitative Health Research|May 3, 2019
Patient Self-worth and Communication Barriers to Trust of Israeli Patients in Acute-Care Physicians at Public General HospitalsGillie Gabay
Hospital Pharmacy|June 25, 2014
A step forward: review of the new california provider status lawMichael Gabay
Pageof 112

Showing results (11-20 of 1,119) with videos related to

Sort By:
Pageof 112
Hospital Pharmacy|December 19, 2018
RxLegal: Pharmacist Gag ClausesMichael Gabay
Hospital Pharmacy|December 26, 2017
Biosimilar Substitution LawsMichael Gabay
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2003
IL-1 trap. Regeneron/NovartisCem Gabay
Advances in Experimental Medicine and Biology|January 1, 1981
Serotonergic-dopaminergic interactions: implications for hyperkinetic disordersS Gabay
Hospital Pharmacy|October 9, 2015
Providing Feedback to Colleagues: A Continual ChallengeMichael Gabay
Hospital Pharmacy|January 30, 2016
Regulation of Internet Pharmacies: A Continuing ChallengeMichael Gabay
Hospital Pharmacy|March 28, 2018
The Prescription Drug User Fee Act: Cause for Concern?Michael Gabay
Omega|May 30, 2019
A Nonheroic Cancer Narrative: Body Deterioration, Grief, Disenfranchised Grief, and GrowthGillie Gabay
Qualitative Health Research|May 3, 2019
Patient Self-worth and Communication Barriers to Trust of Israeli Patients in Acute-Care Physicians at Public General HospitalsGillie Gabay
Hospital Pharmacy|June 25, 2014
A step forward: review of the new california provider status lawMichael Gabay
Pageof 112